Physician profile
Fredda A Patterson
NPI 1447797675
$5,175.90
in general payments reported to CMS, 2019-2025
42 companies · $1,403 in 2025
The $1,403 reported for 2025 was more than what 90% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $151 · 2022: $1,132 · 2023: $1,507 · 2024: $983 · 2025: $1,403.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,768 · Education: $125.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,767.76 |
| Education | $125.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,098.05 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $357.97 | 2024-2025 | Dupixent |
| Astrazeneca Pharmaceuticals LP | $357.70 | 2024-2025 | Tezspire, Breztri, Fasenra |
| Pfizer INC. | $319.67 | 2023-2025 | |
| Novartis Pharmaceuticals Corporation | $279.59 | 2022-2023 | |
| Impel Pharmaceuticals INC. | $230.18 | 2022-2023 | Trudhesa |
| Mdd US Operations, LLC | $214.72 | 2022-2025 | Gocovri, Gocovri, Xadago |
| Actelion Pharmaceuticals US, INC. | $207.49 | 2024-2025 | Opsumit |
| Genzyme Corporation | $164.18 | 2024-2025 | |
| Acadia Pharmaceuticals INC | $157.16 | 2022-2023 | Nuplazid |
| Amgen INC. | $142.39 | 2024-2025 | Tezspire |
| Argenx US, INC. | $107.45 | 2022-2023 | Vyvgart |
| United Therapeutics Corporation | $107.43 | 2024 | Tyvaso |
| Lundbeck LLC | $103.96 | 2025 | Vyepti |
| Grifols USA, LLC | $100.57 | 2022-2025 | Xembify, Gamunex-C |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fredda Patterson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.